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ABSTRACT 
Anaemia during pregnancy is a major public health problem throughout 
the world, particularly in the developing countries. According to WHO, 
prevalence of anaemia in pregnant women is estimated as 14 per cent in 
developed and 51 percent in developing countries. In India the 
prevalence is 65-75 percent. Acharya Kashyapa explained that like other 
disorders Samprapti of Pandu is also similar in Garbhini. So all narration 
mentioned in Ayurvedic classics regarding Pandu is applicable to 
Garbhini- Pandu. In the present study total 37 patients were recruited 
under the study and distributed into two groups Group-A (Draksha 
ghrita) and Group-B (Lakshmana lauha). After completion of trial 30 
patients data was only available for assessment and 07 patients were 
dropped out from the study due to their irregular follow-up. On analysis 
of results, none of the patient has showed excellent relief. 10.00% and 
30.00% patient has showed moderate relief in group A & B respectively. 
06.00% and 10.00% patient in A and B group showed marked relief while 
06.66% and 00.00% patient in has showed mild relief in A and B group 
and also the 26.66% and 16.66% patient has showed no relief. When the 
two groups A and B were compared with each other, the percentage of 
relief is found higher in group B, so it implies that group B is more 
clinically significant than group A. Overall conclusion of this study is that 
Draksha Gritha and Lakshmana lauha both drugs are effective, but 
Lakshmana lauha is comparatively better to cure the Subjective and 
Objective parameter of Garbhini Pandu.  
 
INTRODUCTION
Anaemia during pregnancy is a major public 
health problem throughout the world, particularly 
in the developing countries. According to WHO, 
prevalence of anaemia in developed and developing 
countries in pregnant women is estimated at about 
14 per cent in developed and 51 percent in 
developing countries. In India the prevalence is 65-
75 percent. When compared to other developing 
countries, prevalence of anaemia in all the age 
groups is higher in India[1]. In South Asian countries, 
India contributes approximately 80 percent of the 
maternal deaths due to anaemia[2]. The Indian 
subcontinent alone contains nearly half of the 
world’s anaemic women[3]. Despite the fact that 
most of the anaemia that occur in pregnancy are 
largely preventable and easily treatable if detected 
in time, but still continues to be a common cause of 
mortality and morbidity in India. Anaemia is 
directly responsible for 20% maternal death and is 
an associated cause in another 20%[4]. Margaret 
Balfour was credited as the first to draw the 
attention of anaemia in pregnancy in India[5]. The 
Indian Council of Medical Research estimated the 
prevalence of anaemia among pregnant women to 
be 88%[6]. These affect approximately 2 billion 
people, 80% of whom live in the developing 
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countries[7]. WHO defines anaemia as presence of 
haemoglobin of less than 11g/dl and haemtocrit of 
less than 0.33g/dl. According to a study by WHO on 
anaemia during 1993-2005, worldwide prevalence 
of anaemia was 25%. Iron containing drugs are 
widely used in modern medicine as haematinics. 
These drugs are known to induce some adverse 
drug reactions like gastro intestinal symptoms 
(nausea, vomiting, epigastric pain, eructation, colic 
pain, flatulence, constipation, black faeces, and 
diarrhea[8]. Hence it is the need to search some 
alternative form of other systems medicine. So we 
can try for safe, cheap, non-surgical and side effect 
free alternative. Ayurvedic management for the 
treatment of Garbhini Pandu with Ayurvedic 
preparations. Draksha Ghrita and Lakshmana lauha 
are selected for the study from Chakradatta[9] and 
Bhaishajya ratnavali[10] respectively. Draksha Ghrita 
consists of Draksha and Ghrita and lakshmana lauha 
consists of Lakshmana (Swetakantakari), Ashoka, 
Kusha, Madhuka, Bala, Patha, Bilwa, Yastimadhu, 
and Lauha bhasma. 
Acharya Kashyapa explained that like other 
disorders Pandu is also common disease in 
Garbhini.[11] So all narration mentioned in Ayurvedic 
classics regarding Pandu is same as described in 
Garbhini-Pandu. In a nutshell, these different 
references regarding Garbhini–Pandu described in 
Ayurvedic text are given- Garbhini Pandu is 
exclusively described in Vyakta Garbha 
Lakshanas[12,13] Garbhini Masanumasika 
lakshanas[14], Raktagulma context,[15] eight 
Garbhopadravas[16], Doshika Upavistaka Garbhini 
Lakshanas[17], and Arista Lakshanas of Garbhini[18]. 
Materials and Methods 
All the subjects are recruited from the OPD 
& IPD of Prasutitantra and Streeroga department, 
National Institute of Ayurveda, Jaipur as per the 
inclusion criteria and after obtaining the voluntary 
informed consent. Total 37 patients with confirmed 
diagnosis of Garbhini pandu were selected for the 
study, out of them 30 patients were completed the 
study and seven patients were dropped out. 
Inclusion Criteria  
A pregnant woman willing to participate in the trial. 
• A pregnant woman aged between 18-35 years of 
life. 
• A pregnant woman having anaemia in second 
trimester. 
Exclusion Criteria  
• Anaemia other than Iron deficiency anaemia. 
• Patients having Haemoglobin gm% less than 
8.0gm/dl. 
• Patients suffering from systemic diseases. 
• 1st trimester of pregnancy. 
• Patients suffering from pregnancy related 
complications such as- pregnancy induced 
hypertension (PIH), pre-eclampsia, hyperemesis 
gravidarum. 
Withdrawal Criteria 
The participant was withdrawn from the trial if 
• During the course of clinical trial, if patient 
develops any serious adverse effect which 
requires urgent treatment. 
• Non-compliance of trial. 
• Patient will be excluded if she is irregular. 
Investigations 
Blood Examination- Haemoglobin, Total RBC, PCV, 
MCH, MCV, MCHC, All other routine Antenatal Care 
investigation were done. 
Design of study 
Study Type: Interventional  
Method adopted: Randomized open labelled 
standard control trial  
Institutional Ethical Committee Clearance No. 
IEC/ACA/2017/42 and of date 25-27/04/2017 
Purpose: Treatment  
No. of Group: Two 
No. of Patient’s: 30 
Duration of study and treatment period– 3 
months 
Follow-up period– Patients were examined for the 
change in the signs and symptoms after every 15 
days for a period of 3 months.  
Division in Groups  
Group A-having 15 patients: Draksha ghrita  
Group B –having 15 patients: Lakshmana lauha 
Drug intervention  
Group A: Draksha ghrita was given orally on empty stomach with Ushna udaka 
S.No. Group Name Hb (gm %) Dose Duration 
1. Group-A 8-10 gm% 5gm. 3times/day 
Group B: Laksmana lauha form orally on empty stomach with Sahapana Madhu 
S.No. Group Name Hb (gm %) Dose Duration 
1. Group-B 8-10 gm% 500mg. 3times/day 
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Assessment Criteria 
 Subjective criteria 
• The improvement in the patient was assessed mainly on the basis of relief in the signs and symptoms of 
the disease.  
• To assess the effect of therapy, all the signs and symptoms were given scoring depending upon their 
severity. 
• Subjective symptoms were scored following the standard methods 
Table 1: Scoring pattern for sign & symptoms 
S.No. Features Grading Score 
1 Pallor (Panduta) G0- No pallor 0 
  G1- Pallor restricting itself only to conjunctiva. 1 
  G2- Pallor in conjunctiva, tongue and nails 2 
  G3- Palmar crease and skin is also affected along with 
conjunctiva, tongue and nails. 
3 
2 Anorexia (Aruchi) G0- Normal appetite. 0 
  G1- Unwilling to take food but eat. 1 
  G2- Intake of food decreases. 2 
  G3- No interest to intake food. 3 
3 Indigestion (Avipaka) G0- No indigestion. 0 
  G1- Occasionally present. 1 
  G2- Present most of the time. 2 
  G3- Always present. 3 
4 Giddiness (Bhrama) G0- No Giddiness 0 
  G1- Occasionally present 1 
  G2- Present most of the time 2 
  G3- Always present 3 
5 Fatigueness (Shrama)  G0- No fatigue  0 
  G1- Fatigueness after excessive physical work. 1 
  G2- Fatigueness on routine work  2 
  G3- Fatigueness even on rest  3 
6 Palpitation (Hrid-spandana) G0- No palpitation 0 
  G1- Palpitation on excessive physical work 1 
  G2- Palpitation on routine work 2 
  G3- Palpitation on rest 3 
7 Edema (Shotha) G0- No edema 0 
  G1- Edema in one particular region pedal edema, edema 
around eye ball, face 
1 
  G2- Edema more than two different sites 2 
  G3- Generalized edema 3 
8 Tinnitus (Karnak-shweda) G0- No tinnitus 0 
  G1- Occasionally present 1 
  G2- Present most of the time 2 
  G3- Always present 3 
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9 General-weakness (Daurbalya)  G0- No General-weakness 0 
  G1- General-weakness after excessive physical work. 1 
  G2- General-weakness on routine work  2 
  G3- General-weakness even on rest  3 
10 Leg Cramps (Pindiko-dwestana) G0-No cramps 0 
  G1- Cramps in legs occasionally 1 
  G2- Present most of the time 2 
  G3- Always present 3 
11 Pica (Mrida-bhakshna) 
[Desire of non edible substances] 
G0- No Pica 0 
  G1- Occasionally 1 
  G2- Frequently 2 
  G3- Persistent desire 3 
12 Exertional-dyspnoea (Shwasa) G0- Dyspnoea absent 0 
  G1- Dyspnoea on excessive work 1 
  G2- Dyspnoea on doing routine work 2 
  G3- Dyspnoea on little physical work 3 
13 Pain in upper & lower extremity 
(Kati–Pada-Uru- Ruk) 
G0- No pain 0 
  G1- Pain in upper & lower extremity Occasionally 1 
  G2- Pain present most of the time in upper & lower 
extremity 
2 
  G3-Always present 3 
Objective Parameters 
For the purpose of diagnosis of a disease its assessment, severity and clinical improvement, certain 
routine and specific investigations were performed in every patients viz. 
• Hemoglobin (Hb) 
• Packed Cell Volume (PCV) 
• Mean Corpuscular Volume (MCV) 
• Mean Corpuscular Hemoglobin (MCH) 
• Mean Corpuscular hemoglobin Concentration (MCHC) 
Criteria for the assessment of overall effect of the therapy 
 The total effect of treatment was assessed in the terms of cured, moderate improvement, mild 
improvement and no change. 
Table 2: Assessment Criteria of Overall Effect of Therapy 
No change < 25% changes in the signs and symptoms 
Mild improvement 26-50% changes in the signs and symptoms 
Moderate improvement 51-75% relief in the signs and symptoms 
Marked improvement 76-99% relief in the signs and symptoms 
Complete cure 100% relief in the signs and symptoms 
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Observations 
Table 3: Age Wise Distribution of Patients of Garbhini Pandu (n=37) 
AGE (years) 
No. of Patients 
Total % 
Group A Group B 
18-23 07 08 15 40.54 
24-29 10 09 19 51.35 
30-35 01 02 3 08.11 
Total 18 19 37 100% 
 Above table shows that the maximum incidence of Garbhini-Pandu i.e., 19 (51.35%) patients was found in 
age group ranging from 24-29 years followed by 15(40.54%) patients were from age group 18-23 years and 
3 (08.11%) patients were from 30-35 years. 
Table 4: Religion Wise Distribution of Patients of Garbhini Pandu (n=37) 
Religion 
No. of Patients 
Total Percentage 
Group A Group B 
Hindu 12 9 21 56.76% 
Muslim 6 10 16 43.24% 
Other 00 00 00 00 % 
Total 18 19 37 100% 
Out of 37 patients 21 (56.76%) patients were from Hindu community and 16 (43.24%) from Muslim 
community.  
Table 5: Occupation of Patient-wise Distribution of Patients of Garbhini Pandu (n=37) 
Occupation 
No. of Patients 
Total Percentage 
Group A Group B 
Housewife 18 19 37 100% 
Service class 00 00 00 00% 
Labor class 00 00 00 00% 
Total 18 19 37 100% 
On considering the nature of occupation, it was found that 37(100%) patients were house-wife’s, 
none of the patient belong to service-class group and labor class group.  
Table 6: Socio-economic Status Wise Distribution of Patients of Garbhini Pandu (n=37) 
Socioeconomic status 
No. of Patients 
Total % 
Group A Group B 
Poor 00 00  00 00% 
Lower class 06 07 13 35.14% 
Middle class 12 12 24 64.86% 
Total 18 19 37 100% 
This study revealed that the maximum number of patients i.e. 24 (64.86%) patients were belonging from 
middle class, whereas 13 (35.14%) patients belonging from Lower class. 
Table 7: Habitat wise distribution of patients of GarbhiniPandu (n=37) 
Habitat 
No. of Patients 
Total % 
Group A Group B 
Urban  18 18 36 97.30% 
Rural 00 01 01 02.70% 
Total 18 19 37 100% 
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On considering habitat wise distribution of patients, study reveals that maximum patients i.e. 36 
(97.30%) patients were belonging from urban habitat, while 01 (02.70%) patients were belonging from 
rural area. 
RESULTS 
Table 8. Intergroup Comparison of Subjective Parameters  
To access the efficacy of two therapies intergroup comparison was done. As the variables are nonparametric 
we used Mann-Whitney Test for statistically analysis. The results are as follows 
Intergroup Comparison of Objective Parameters 
The intergroup comparison of objective parameters of both group A and B, evaluated by the unpaired T –test 
and we found that, there is no statistical difference in the efficacy of both treatments  
Table 9: Intergroup Comparison of Therapy’s Effect on Laboratory Investigation Score (Group- A n= 
15, Group- B n= 15)  
Variable Mean Diff. SD± SE± T P Result 
Group A Group B Group A Group B Group A Group B 
Hb Gm. % -0.8267 -1.353 1.116 1.130 0.2881 0.2918 1.284 0.2095 NS 
RBC'S 
(million) 
-0.1780 -0.1780 0.3843 0.3843 0.0992 0.0992 0.000 >0.9999 NS 
PCV in 
percentage 
-0.6733 -0.1933 0.8311 0.5338 0.2146 0.1378 1.882 0.0703 NS 
MCV (fl) 0.5400 0.2067 5.044 4.786 1.300 1.236 0.1857 0.8540 NS 
MCH (pg) 0.3267 1.013 2.238 3.464 0.5780 0.8944 0.6448 0.5243 NS 
MCHC (gm/ 
dl) 
-0.3000 -0.1867 1.541 1.002 0.3980 0.2587 0.2388 0.8130 NS 
 
 
 
 
 
Variable Mean Diff. SD± SE± P Result 
Group 
A 
Group 
B 
Group 
A 
Group 
B 
Group 
A 
Group 
B 
Pallor 1.333 1.267 0.6172 0.4577 0.1594 0.1182 0.6577 NS 
Anorexia 0.866 0.933 0.5164 0.4577 0.1333 0.1182 0.7150 NS 
Digestion 1.000 1.067 0.5345 0.5936 0.1380 0.1533 0.7577 NS 
Dizziness 0.933 1.067 0.4577 0.4577 0.1182 0.1182 0.4395 NS 
Fatigue 0.333 1.267 2.637 0.4577 0.6808 0.1182 0.1106 NS 
Palpitation 1.000 0.933 0.6547 0.5936 0.1690 0.1533 0.7901 NS 
Edema 0.200 0.266 0.5606 0.4577 0.1447 0.1182 0.7953 NS 
Tinnitus 0.333 0.133 0.488 0.3519 0.1260 0.0908 0.2132 NS 
Weakness 0.400 0.733 0.5071 0.7988 0.1309 0.2063 0.2386 NS 
Leg cramps 0.333 0.466 0.4880 0.6399 0.1260 0.1652 0.6400 NS 
Pica 0.200 0.266 0.4140 0.4577 0.1069 0.1182 0.6920 NS 
Dyspnea 0.533 0.533 0.5164 0.6399 0.1333 0.1652 0.8875 NS 
Pain in upper and 
lowar extremities 
0.600 0.733 0.5071 0.7037 0.1309 0.1817 0.6907 NS 
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Table 10: Distribution of Patient According to Relief in Garbhini Pandu (Group- A - n= 15, Group- B - 
n= 15)  
Relief   Group A   Group B  Total  
Patient  Percentage (%) Patient  Percentage (%) Patient  Percentage (%) 
No relief 09 to <10 08 26.66 5 16.66 13 43.33 
Mild 10 To <11 02 06.66 00 00.00 02 06.66 
Moderate 11 to < 12 03 10.00 06 20.00 09 30.00 
Marked 12 to 13 02 06.00 03 10.00 06 16.00 
Excellent > 13 00 00.00 00 00.00 00 00.00 
Total 15      
DISCUSSION 
The present study is carried to evaluate two 
important Ayurvedic preparations Drakshadi ghrita 
and Lakshmana lauha in the management of 
Garbhini Pandu vis-à-vis Pregnancy Anemia. Total 
37 patients recruited under the study and 
distributed into two groups Group-A (Drakshadi 
ghrita group) and Group-B (Lakshmana lauha 
group). After completion of trial 30 patients data 
only available for assessment and 07 patients were 
dropped out from the study due to their irregular 
follow-up. 
Demographic data 
The maximum incidence of Garbhini- Pandu 
i.e., 19 (51.35%) patients was found in age group 
ranging from 24-29 years followed by 15 (40.54%) 
patients were from age group 18-23 years and 03 
(08.11%) patients were from 30-35 years. Out of 37 
patients 21 (56.76%) patients were from Hindu 
community and 16 (43.24%) from Muslim 
community. Prevalence of patients in this study 
shows that primary educated patients were 
maximum i.e. 15 (40.54%), followed by 13 
(35.13%) patients were educated up to middle 
school. Whereas 01 (2.7%) patients were educated 
up to secondary. 04 (21.62%) patients were 
graduate educated. On considering the nature of 
occupation, it was found that 37 (100%) patients 
were house-wives; none of the patient belongs to 
service-class group and labor class group. The 
maximum number of patients i.e. 24 (64.86%) 
patients were belonging from middle class, whereas 
13 (35.13%) patients belonging from Lower class. 
On considering habitat wise distribution of patients, 
study reveals that maximum patients i.e. 36 
(97.29%) patients were belonging from urban 
habitat, while 01 (02.70%) patients were belonging 
from rural area. (Table: 07) 
Interpretation of Results 
The assessment of the result was done by 
adopting method of scoring of sign and symptoms. 
All the observations regarding the change in 
Panduta (Pallor), Aruchi (Anorexia), Avipaka 
(Indigestion), Bharma (Giddiness), Sharma 
(Fatigue), Hrid-spandana (Palpitation), Shotha 
(Edema), Karna-Kshweda (Tinnitus), Daurbalya 
(General weakness), Pindikodwestana (Leg-
cramps), Mrida-bhakshana (Pica), Shwasa 
(Exertional- dyspnoea) and Kati, Pada, Uru, Ruk 
(Pain in upper & lower extremities) were assessed. 
Effects of both medicines were also assessed in 
haematological investigations and result was 
assessed statistically. 
Effect of Therapy on Subjective Criteria 
Effect on Panduta (pallor): Percentage of relief 
was 71.39% and 90.5% in group A & Group B 
respectively in relieving Panduta, and statistically 
both groups are found extremely significant 
(P<<0.0001 ). 
Effect on Aruchi (Anorexia): Both groups were 
found extremely significant (P < 0.0002.) in 
reducing the Aruchi (Anorexia) symptom in 
patients. However, in percentage group- A showed 
better results (72.16%) in comparison to group-B 
(63.59%).  
Effect on Avipaka (Indigestion): In both groups 
extremely significant relief (P<0.0002) found in 
giving relief from Avipaka (Indigestion) of patients. 
However, group-A showed better results (72.16 %) 
in comparison to group B (61.56%). 
Effect on Dizziness Bhrama (Giddiness): In both 
groups, statistically significant (P<0.0001) relief 
observed in Bhrama (Giddiness) of patients. 
However, group B showed more results (66.6%) in 
comparison to groups A (58.31%). 
Effect on Shrama (Fatigue): In Group B, 76.00% of 
relief found in Shrama (fatigue) was extremely 
significant (P<0.0001), whereas in group A 19.97% 
relief seen in shrama and was clinically significant. 
Hence it can be concluded that Group B showed 
better results in comparison to group A. 
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Effect on Hrid- spandana (Palpitation): In Group 
B 69.99% patients showed relief in Hrid- spandana 
and extremely significant (P< 0.000) and in group A, 
57.70% relief was found in Hrid-spandana. 
However, Group B showed more results in 
comparison to group A. 
Effect on Karna- Kshweda (Tinnitus): In Group B 
(50.00%) relief in Karna- Kshweda was found not 
quite significant (P<0.5000.) and in group A 45.42% 
patients are only have found relief in Karna-
Kshweda and is not quite significant. So Group B is 
better than group-A, when compared both.  
Effect on Daurbalya (General weakness): In 
Group B 61.08% relief found in relief of Daurbalya 
and is very significant (P<0.0039) and in Group A 
(50.00%) relief in Daurbalya is significant. 
However, Group B had shown more effect in 
comparison to Group A.  
Effect on Pindikodveshtana (Leg-cramps): In 
Group B (63.57%) relief in Pindikodveshtana is 
significant and in Group A (45.42%) relief in 
Pindikodvestana is not quite significant. However, 
Group B showed more results in comparison to 
Group A.  
Mrid- bhakshana (Pica): Both groups were 
clinically not significant in reducing Mrida- 
bhakshana (Goup A- 37.52% & Group B- 57.08%).  
Shvasa (Exertional dyspnoea): In Group B 
(72.71%) relief in Shwasa is very significant and in 
group A (49.95%) relief in Shwasa is significant. 
However, Group B showed better results in 
comparison to group A.  
Kati, Pada, Uru, Ruk (Pain in upper & lower 
extremities): In Group B (68.69%) relief in Kati, 
Pada, Uru, Ruk is very significant and in group A 
(56.23%) relief in Kati, Pada, Uru, Ruk is very 
significant. However, Group B showed more results 
in comparison to group A.  
Effect on Objective Parameters 
Haemoglobin: 
In Group B (14.47%) shown extremely 
significant result whereas in group A (8.76%) was 
significant. Group B shown better result than Group 
A.  
In group A the percentage of relief was 
8.762% and the effect of the therapy was significant 
at P<0.05. 
In group B the percentage of relief was 
14.47% and the effect of the therapy was extremely 
significant at P<0.01. 
Red Blood Corpuscles 
In Group A (4.8%) shows quite significant 
result and group B (1.35%) shows not significant. 
In group A the percentage of relief was 4.896% and 
the effect of the therapy was not quite significant at 
P>0.05. 
In group B the percentage of relief was 
1.352% and the effect of the therapy was not 
significant at P>0.05. 
Packed Cell Volume (PCV) in percentage 
In Group A (2.2%) shows very significant 
result and in group B (0.5%) shows not significant. 
In group A the percentage of relief was 
2.260% and the effect of the therapy was very 
significant at P<0.01. 
In group B the percentage of relief was 
0.585% and the effect of the therapy was not 
significant at P>0.05. 
Probable Mode of Action of Trial Drugs 
Draksha ghrita 
Draksha ghrita collectively has Madhura, 
Tikta and Kashaya Rasa, Guru Snigdha, Mridu and 
Saumya Guna, Madhura Vipaka and Sheeta Veerya. It 
has got Vata-Pitta Shamaka especially Pitta-
Shamaka property. Because of the presence of 
Ghrita it also enhances or stimulates the digestive 
power and hence it cures Agnimanda due to 
Agnivardhaka prabhava of Ghrita and thereby helps 
in removal of Srotavarodha. Draksha have Virechaka 
prabhava due to which it also normalizes vitiated 
Pitta dosha. 
Pandu though it is a Tridoshaja disease, but 
main Dosha taking part in Samprapti is Pitta. Due to 
Vata-Pitta Samaka, agnivardhaka properties, 
Virechaka Guna, Draksha ghrita pacifies Pitta, 
removes Shrotovaigunya and further helps in the 
optimum formation of rasa well as Rakta dhatu 
formation. 
According to Ayurveda Draksha has got 
Anulomana, Hridya, Jeevaniya, Balya, Brumhana, 
Mrudu rechaka properties. Raisins contain calcium, 
magnesium, potassium, phosphorus and iron in an 
assimilable form besides gum and sugar. It is rich in 
anti-oxidants. 
 Lakshmana lauha  
Lakshamana Lauha is having 
Tridoshashamaka as well as Rakta-vardhaka, 
Agnidipaka, and Kriminashaka property. Pandu is a 
disease that occurs due to Agnimanda (diminished 
metabolic fire) and Stroto avrodha (obstruction in 
the minute channels). Bala, Yashtimadhu, Madhuka, 
Bilva, Lauha bhasma and other ingredients present 
in Lakshamana Lauha are able to cause Vighatana of 
Samprapti of Pandu through their Madhura, Tikta, 
Kashyarasa properties and also Improves the 
formation of Rakta dhatu.  
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Good quality proteins play a significant role 
in iron absorption from the intestines, such as 
hespidin, DMT-1, ceruloplasmin and are also helps 
in efflux of iron from enterocytes. Iron supplements 
require bioavailability enhancers to minimize the 
side effects. Herbo-mineral formulations can be 
used to reduce various side effects as the processing 
of various herbal juices with already processed and 
micro-fined minerals lead to the formation of 
herbo- mineral complexes. These complexes upon 
interaction with digestive juices adopt a colloidal 
form, for faster absorption. Sometimes they play a 
catalytic role facilitating absorption of other 
nutrients and correcting a disease process[19]. 
The fraction of iron absorbed from the 
amount ingested is typically low, but may range 
from 5% to 35% depending on circumstances and 
type of iron[20]. The physical state of iron entering 
the duodenum greatly influences its absorption. At 
physiological pH, ferrous iron (Fe+2) is rapidly 
oxidized to the insoluble ferric (Fe+3) form. Gastric 
acid lowers the pH of the proximal part of the 
duodenum, and then reduces Fe+3 in the intestinal 
lumen by ferric reductases, and thus allows the 
subsequent transport of Fe+2 across the apical 
membrane of enterocytes. This enhances the 
solubility and uptake of ferric iron[21]. When gastric 
acid production is impaired, like in cases of Pandu 
(Anemia) roga, iron absorption is reduced 
substantially. 
Lakshmana Lauha is a herbo-mineral drug, 
Lauha content and presence of other herbs like 
Yashtimadhu, Bilva may be forming herbo-mineral 
complexes and facilitating the absorption of iron. 
Yashtimadhu (Glycyrrhiza glabra L.) is Rasayana 
and active bio-availability enhancer[22]. The drug 
Bilva is having Anulomana (laxative) and anti-
oxidant properties. The drug Bala present in this 
compound is also a Rasayana drug; hence it acts as 
tonic and helps in absorption and bio-availability of 
Lauha in the intestines and formation of Rasa as 
well as Raktadhatus.  
Another ingredient present in this drug is 
Bilva (Aegle marmelos (Linn.) Correaex. Roxb). Its 
fruit is commonly used at house-hole level to 
prepare juice, Sharbat, jelly etc. It is used as 
medicine as well as a nutraceutical plant. It is 
having Kashaya, Tikta rasa, Laghu, Ruksha guna, 
Ushna veerya, Katu vipaka, and Kapha, Vata 
shamaka properties. It is having therapeutic 
properties like Deepana, Pachana, Grahi, 
Shothahara, Krimighna, Mridurechana, Pittasaraka, 
Vedanasthapana. In Ayurveda classics it is 
suggested to use in Atisara, Pravahika, Vamana, 
Vataroga, Agnimandya, Grahani, Raktatisara, 
Raktapravahika, Raktarsha, Vibandha, Kamala, 
Vishuchika, Madhumeha, Parshvashula etc. It is 
found to have protein 1.8; fat 0.3; carbohydrates 
31.8 and fibre 2.9g/100g; calcium 85.0; phosphorus 
50.0, iron 0.6; thiamine 0.13; riboflavin 1.2, niacin 
1.1, oxalic acid 18.7; and vitamin C 8.0mg/100gm; 
carotene 55micro grams/100g; and calorific value 
137KCal/100g. Mridurechana and Agnimandyahara 
properties of this drug helps in pacifying Pitta.  
Yashtimadhu is a good source of vitamin C; 
carotene, nicotinic acid, riboflavin. Yashti in 
association with Bilva through their Vitamin-C rich 
property helps in the absorption of iron in the 
intestines. 
CONCLUSION 
Excellent relief was not found in both 
groups, moderate relief was seen in 10.00% of 
patient in group-A, and in 30.00% patients B. In 
group-A, 06.00% and 10.00% patients in group-B 
showed marked relief while 0.6.66% and 00.00% 
patients has showed mild relief in A and B group 
respectively. And in Group A 26.66% and in Group 
B 16.66% patient has showed no relief. When the 
two groups A and B were compared with each 
other, the percentage of relief is found higher in 
group B, so it implies that group B is more clinically 
significant than group A. 
Overall conclusion of this is that Draksha 
Gritha and Lakshmana lauha both drugs are 
effective, but Lakshmana lauha is comparatively 
better to cure the Subjective and Objective 
parameter of Garbhini Pandu. 
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